Cargando…
Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Endocrine Society
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164502/ https://www.ncbi.nlm.nih.gov/pubmed/37150517 http://dx.doi.org/10.3803/EnM.2023.201 |
| _version_ | 1785038081382940672 |
|---|---|
| author | Cho, Eun-Hee |
| author_facet | Cho, Eun-Hee |
| author_sort | Cho, Eun-Hee |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10164502 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Korean Endocrine Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101645022023-05-08 Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy Cho, Eun-Hee Endocrinol Metab (Seoul) Editorial Korean Endocrine Society 2023-04 2023-04-27 /pmc/articles/PMC10164502/ /pubmed/37150517 http://dx.doi.org/10.3803/EnM.2023.201 Text en Copyright © 2023 Korean Endocrine Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Cho, Eun-Hee Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy |
| title | Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy |
| title_full | Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy |
| title_fullStr | Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy |
| title_full_unstemmed | Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy |
| title_short | Glucocorticoids as a Double-Edged Sword in the Treatment of COVID-19: Mortality and Severity of COVID-19 in Patients Receiving Long-Term Glucocorticoid Therapy |
| title_sort | glucocorticoids as a double-edged sword in the treatment of covid-19: mortality and severity of covid-19 in patients receiving long-term glucocorticoid therapy |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164502/ https://www.ncbi.nlm.nih.gov/pubmed/37150517 http://dx.doi.org/10.3803/EnM.2023.201 |
| work_keys_str_mv | AT choeunhee glucocorticoidsasadoubleedgedswordinthetreatmentofcovid19mortalityandseverityofcovid19inpatientsreceivinglongtermglucocorticoidtherapy |